SPX3,647.29-7.75 -0.21%
DIA291.30-1.42 -0.49%
IXIC10,829.50+26.58 0.25%

Mindset Pharma Receives Advice from UK Regulator Facilitating Advancement of Phase 1 Clinical Trial Plan For MSP-1014

Mindset Pharma Receives Advice from UK Regulator Facilitating Advancement of Phase 1 Clinical Trial Plan For MSP-1014

MT Newswires · 09/14/2022 04:50

Please log in to view news